Kohlberg Kravis Roberts & Co »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $830k 800k 1.04

More positions owned by Kohlberg Kravis Roberts & Co

Brightspring Health Svcs (BTSG)
Henry Schein (HSIC)
Bridgebio Pharma (BBIO)
Crescent Energy Company Cl A Com (CRGY)
Niq Global Intelligence Ordinary Shares (NIQ)
Brightview Holdings (BV)
Kkr Real Estate Finance Trust (KREF)
Paramount Skydance Corp Com Cl B (PSKY)
American Wtr Cap Corp Note 3.625% 6/1 (Principal)
Block Note 5/0 (Principal)
Oxford Lane Cap Corp (OXLC)
Bausch Health Companies (BHC)
Northern Oil & Gas Note 3.625% 4/1 (Principal)
Immunocore Hldgs Note 2.500% 2/0 (Principal)
Sabre Glbl Note 7.320% 8/0 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Context Capital Management
Bnp Paribas Arbitrage, Snc
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management
SSI Investment Management
Ing Investment Management
UBS Group

View all funds holding Arrowhead Pharmaceuticals In Note 1/1